Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical Companies

JAMA Dermatol. 2020 Oct 1;156(10):1136-1138. doi: 10.1001/jamadermatol.2020.2685.

Abstract

This economic evaluation reviews the trends in list and net price data from SSR Health for the 2007 to 2019 period of self-administered systemic psoriasis medications manufactured in the United States.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biological Products / administration & dosage
  • Biological Products / economics*
  • Cost of Illness
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / economics*
  • Drug Costs / statistics & numerical data
  • Drug Costs / trends*
  • Drug Industry / economics
  • Drug Industry / statistics & numerical data
  • Drug Industry / trends*
  • Financial Support
  • Health Expenditures / statistics & numerical data
  • Health Expenditures / trends*
  • Humans
  • Psoriasis / drug therapy*
  • Psoriasis / economics
  • Self Administration / economics
  • Self Administration / statistics & numerical data
  • United States

Substances

  • Biological Products
  • Dermatologic Agents